Cantor Fitzgerald Starts Acacia Research (ACTG) at Buy; The Greenest Thumb in Patent-land

Cantor Fitzgerald initiates coverage on Acacia Research (NASDAQ: ACTG) with a Buy. PT $45.00.

Cantor analyst says, "Until recently, patents have been a defensive asset class, used principally as an impassive insurance policy for its holder's core business, with rights-assertion (costly and risky litigation) being an unsavory last resort. However, Acacia has since demonstrated that patents can be monetized with increasing ease, little risk, and no capital intensity. Thus, a virtuous cycle has evolved, where IP holders (small and increasingly large) partner with ACTG to unlock IP value, while larger companies increasingly settle and/or preemptively license Acacia's burgeoning patent portfolio. Along these lines, ACTG's 192 IP portfolios and 1,050 agreements, have generated $500M+ in licensing revenues, while Oracle (Nasdaq: ORCL), Microsoft (Nasdaq: MSFT), and Samsung have already signed comprehensive IP litigation-protection agreements (span a few years)."

For an analyst ratings summary and ratings history on Acacia Research click here. For more ratings news on Acacia Research click here.

Shares of Acacia Research closed at $30.69 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Cantor Fitzgerald Downgrades Better Home & Finance Holding (BETR) to Neutral
• BofA Securities Resumes American Eagle Outfitters (AEO) at Underperform
• Axis Capital Limited Assumes Jubilant Foodworks Ltd (JUBI:IN) at Reduce (3)